Literature DB >> 12384425

Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.

Young-June Kim1, Randy R Brutkiewicz, Hal E Broxmeyer.   

Abstract

The CD28(-) subset of CD8(+) T cells is associated with cytotoxic T lymphocyte (CTL) effector function. We investigated a potential role for 4-1BB, a costimulatory molecule structurally related to members of the tumor necrosis factor (TNF) receptor family, in the generation and functional activation of CD28(-) CTLs by using human cord blood (CB) cells composed exclusively of naive CD8(+) T cells with few or no CD28(-) CTLs. The 4-1BB was induced preferentially on the CB CD28(-)CD8(+) T cells when CD28 down-regulation was induced by interleukin 15 (IL-15) and IL-12 stimulation. Anti-4-1BB costimulation induced dramatic phenotypic changes in the CD28(-) CTLs, including restoration of CD28 expression as well as that of memory markers such as CD45RO and CC chemokine receptor 6 (CCR6). Anti-4-1BB costimulation also promoted long-term survival of CD28(-) CTLs, which were sensitive to activation-induced cell death upon anti-CD3 stimulation. The memory-type CD28(+) CTLs induced by anti-4-1BB costimulation acquired a greatly enhanced content of granzyme B, a cytolytic mediator, and enhanced cytotoxic activity as compared with CD28(-) CTLs. Strong cytotoxicity of memory-type CTLs to a 4-1BB ligand-expressing Epstein-Barr virus (EBV)-transformed B-cell line was almost completely abrogated by 4-1BB-Fc, a soluble form of 4-1BB, suggesting involvement of 4-1BB in cytolytic processes. Taken all together, our results suggest that 4-1BB plays a role in the differentiation of effector memory CTLs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384425     DOI: 10.1182/blood-2001-11-0136

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

Authors:  Hal E Broxmeyer; Man-Ryul Lee; Giao Hangoc; Scott Cooper; Nutan Prasain; Young-June Kim; Coleen Mallett; Zhaohui Ye; Scott Witting; Kenneth Cornetta; Linzhao Cheng; Mervin C Yoder
Journal:  Blood       Date:  2011-03-10       Impact factor: 22.113

Review 2.  Challenges in umbilical cord blood stem cell banking for stem cell reviews and reports.

Authors:  Karen Ballen
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

3.  4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease.

Authors:  Douglas G Mack; Allison K Lanham; Brent E Palmer; Lisa A Maier; Tania H Watts; Andrew P Fontenot
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

4.  Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy.

Authors:  Daniel J Powell; Mark E Dudley; Paul F Robbins; Steven A Rosenberg
Journal:  Blood       Date:  2004-09-02       Impact factor: 22.113

5.  Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo.

Authors:  Xiaocai Yan; Bryon D Johnson; Rimas J Orentas
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

Review 6.  Dynamics of T cell memory in human cytomegalovirus infection.

Authors:  Edward C P Waller; Elizabeth Day; J G Patrick Sissons; Mark R Wills
Journal:  Med Microbiol Immunol       Date:  2008-02-27       Impact factor: 3.402

7.  Targeting the 4-1BB costimulatory molecule through single chain antibodies promotes the human T-cell response.

Authors:  Salman Bagheri; Elmira Safaie Qamsari; Mehdi Yousefi; Farhad Riazi-Rad; Zahra Sharifzadeh
Journal:  Cell Mol Biol Lett       Date:  2020-04-22       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.